(-)-demecolcine decreases expression ISO RGD:1353912 6480464 Demecolcine results in decreased expression of HDAC9 mRNA CTD PMID:23649840 17beta-estradiol multiple interactions ISO RGD:1353912 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of HDAC9 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:1353912 6480464 Estradiol results in decreased expression of HDAC9 mRNA CTD PMID:32030086 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HDAC9 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HDAC9 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HDAC9 mRNA CTD PMID:22493514 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614254 6480464 Tetrachlorodibenzodioxin results in decreased expression of HDAC9 mRNA CTD PMID:19933214 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1614254 6480464 tetrabromobisphenol A results in decreased expression of HDAC9 mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1614254 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of HDAC9 mRNA CTD PMID:26251327 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:1614254 6480464 Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA CTD PMID:18098314 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:1614254 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] CTD PMID:18098314 4,4'-sulfonyldiphenol increases methylation ISO RGD:1353912 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of HDAC9 gene CTD PMID:31601247 5-aza-2'-deoxycytidine decreases expression ISO RGD:1614254 6480464 Decitabine results in decreased expression of HDAC9 mRNA CTD PMID:27915011 5-fluorouracil increases expression ISO RGD:1353912 6480464 Fluorouracil results in increased expression of HDAC9 mRNA CTD PMID:24737281 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of HDAC9 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of HDAC9 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1614254 6480464 Acrylamide results in decreased expression of HDAC9 mRNA CTD PMID:30807115 aflatoxin B1 decreases methylation ISO RGD:1353912 6480464 Aflatoxin B1 results in decreased methylation of HDAC9 gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1353912 6480464 Aflatoxin B1 results in increased methylation of HDAC9 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1353912 6480464 Tretinoin results in decreased expression of HDAC9 mRNA CTD PMID:21934132 antirheumatic drug increases expression ISO RGD:1353912 6480464 Antirheumatic Agents results in increased expression of HDAC9 mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1353912 6480464 aristolochic acid I results in increased expression of HDAC9 mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:1614254 6480464 arsenite results in increased expression of HDAC9 mRNA CTD PMID:33053406 benzo[a]pyrene affects methylation ISO RGD:1353912 6480464 Benzo(a)pyrene affects the methylation of HDAC9 intron, Benzo(a)pyrene affects the methylation of HDAC9 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1353912 6480464 Benzo(a)pyrene results in increased expression of HDAC9 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1614254 6480464 Benzo(a)pyrene results in increased methylation of HDAC9 intron CTD PMID:27901495 benzo[e]pyrene decreases methylation ISO RGD:1353912 6480464 benzo(e)pyrene results in decreased methylation of HDAC9 intron CTD PMID:30157460 berberine decreases expression ISO RGD:1353912 6480464 Berberine results in decreased expression of HDAC9 mRNA CTD PMID:27311644 berberine increases expression ISO RGD:1353912 6480464 Berberine results in increased expression of HDAC9 mRNA CTD PMID:27311644 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1614254 6480464 Mustard Gas results in decreased expression of HDAC9 mRNA CTD PMID:26392148 bisphenol A decreases expression ISO RGD:1353912 6480464 bisphenol A results in decreased expression of HDAC9 mRNA CTD PMID:22576693 , PMID:32030086 bisphenol A affects methylation ISO RGD:1353912 6480464 bisphenol A affects the methylation of HDAC9 gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HDAC9 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HDAC9 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1353912 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of HDAC9 gene CTD PMID:31601247 cadmium atom multiple interactions ISO RGD:1614254 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of HDAC9 mRNA CTD PMID:31904401 cadmium dichloride multiple interactions ISO RGD:1614254 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of HDAC9 mRNA CTD PMID:31904401 CGP 52608 multiple interactions ISO RGD:1353912 6480464 CGP 52608 promotes the reaction [RORA protein binds to HDAC9 gene] CTD PMID:28238834 chloroprene decreases expression ISO RGD:1614254 6480464 Chloroprene results in decreased expression of HDAC9 mRNA CTD PMID:23125180 cisplatin multiple interactions ISO RGD:1353912 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of HDAC9 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of HDAC9 mRNA] CTD PMID:27392435 dorsomorphin multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1353912 6480464 Doxorubicin results in decreased expression of HDAC9 mRNA CTD PMID:29803840 entinostat multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HDAC9 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1353912 6480464 entinostat results in decreased expression of HDAC9 mRNA CTD PMID:26272509 ethyl methanesulfonate decreases expression ISO RGD:1353912 6480464 Ethyl Methanesulfonate results in decreased expression of HDAC9 mRNA CTD PMID:23649840 folic acid decreases expression ISO RGD:1614254 6480464 Folic Acid results in decreased expression of HDAC9 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1353912 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of HDAC9 gene CTD PMID:31601247 fulvestrant decreases methylation ISO RGD:1353912 6480464 Fulvestrant results in decreased methylation of HDAC9 gene CTD PMID:31601247 gemcitabine increases expression ISO RGD:1353912 6480464 gemcitabine results in increased expression of HDAC9 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:1614254 6480464 Genistein results in decreased expression of HDAC9 mRNA CTD PMID:32186404 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of HDAC9 mRNA CTD PMID:24915197 hydroquinone increases expression ISO RGD:1353912 6480464 hydroquinone results in increased expression of HDAC9 mRNA CTD PMID:31256213 indometacin increases expression ISO RGD:1353912 6480464 Indomethacin results in increased expression of HDAC9 mRNA CTD PMID:24737281 lead diacetate increases expression ISO RGD:1614254 6480464 lead acetate results in increased expression of HDAC9 mRNA CTD PMID:20542052 lipopolysaccharide decreases expression ISO RGD:1614254 6480464 Lipopolysaccharides results in decreased expression of HDAC9 mRNA CTD PMID:25890327 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of HDAC9 mRNA CTD PMID:25452209 methapyrilene decreases methylation ISO RGD:1353912 6480464 Methapyrilene results in decreased methylation of HDAC9 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO RGD:1353912 6480464 Methyl Methanesulfonate results in decreased expression of HDAC9 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1353912 6480464 methylmercuric chloride results in decreased expression of HDAC9 mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:1353912 6480464 HDAC9 protein affects the susceptibility to Mitomycin CTD PMID:16217747 paclitaxel increases response to substance ISO RGD:1353912 6480464 HDAC9 protein results in increased susceptibility to Paclitaxel CTD PMID:16734730 panobinostat decreases expression ISO RGD:1353912 6480464 Panobinostat results in decreased expression of HDAC9 mRNA CTD PMID:30481203 paracetamol increases expression ISO RGD:1353912 6480464 Acetaminophen results in increased expression of HDAC9 mRNA CTD PMID:29067470 PD 0325901 decreases expression ISO RGD:1353912 6480464 mirdametinib results in decreased expression of HDAC9 mRNA CTD PMID:25119042 PD 0325901 multiple interactions ISO RGD:1353912 6480464 [(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of HDAC9 mRNA CTD PMID:25119042 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1614254 6480464 [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of HDAC9 mRNA CTD PMID:31904401 picoxystrobin decreases expression ISO RGD:1353912 6480464 picoxystrobin results in decreased expression of HDAC9 mRNA CTD PMID:33512557 pirfenidone decreases expression ISO RGD:1353912 6480464 pirfenidone results in decreased expression of HDAC9 mRNA CTD PMID:30481203 resveratrol increases expression ISO RGD:1353912 6480464 Resveratrol results in increased expression of HDAC9 mRNA CTD PMID:30481203 S-adenosyl-L-methioninate multiple interactions ISO RGD:1614254 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] CTD PMID:18098314 S-adenosyl-L-methionine multiple interactions ISO RGD:1614254 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] CTD PMID:18098314 SB 431542 multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1353912 6480464 Silicon Dioxide results in increased expression of HDAC9 mRNA CTD PMID:22300531 , PMID:25351596 silver atom decreases expression ISO RGD:1614254 6480464 Silver results in decreased expression of HDAC9 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1614254 6480464 Silver results in decreased expression of HDAC9 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:1353912 6480464 sodium arsenite results in increased expression of HDAC9 mRNA CTD PMID:16966095 , PMID:32844245 succimer multiple interactions ISO RGD:1353912 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HDAC9 mRNA CTD PMID:26378955 sulforaphane decreases expression ISO RGD:1353912 6480464 sulforaphane results in decreased expression of HDAC9 mRNA CTD PMID:26833863 sunitinib decreases expression ISO RGD:1353912 6480464 Sunitinib results in decreased expression of HDAC9 mRNA CTD PMID:31533062 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HDAC9 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1614254 6480464 Carbon Tetrachloride results in increased expression of HDAC9 mRNA CTD PMID:27396813 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HDAC9 mRNA CTD PMID:31150632 titanium dioxide decreases expression ISO RGD:1353912 6480464 titanium dioxide results in decreased expression of HDAC9 mRNA CTD PMID:33064449 topotecan affects response to substance ISO RGD:1353912 6480464 HDAC9 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A decreases expression ISO RGD:1353912 6480464 trichostatin A results in decreased expression of HDAC9 mRNA CTD PMID:22723015 more ... trichostatin A multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HDAC9 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1353912 6480464 Triclosan results in decreased expression of HDAC9 mRNA CTD PMID:30510588 valproic acid decreases expression ISO RGD:1353912 6480464 Valproic Acid results in decreased expression of HDAC9 mRNA CTD PMID:24383497 , PMID:26272509 valproic acid increases methylation ISO RGD:1353912 6480464 Valproic Acid results in increased methylation of HDAC9 gene CTD PMID:29501571 valproic acid affects expression ISO RGD:1353912 6480464 Valproic Acid affects the expression of HDAC9 mRNA CTD PMID:29501571 valproic acid multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HDAC9 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1353912 6480464 Valproic Acid results in increased expression of HDAC9 mRNA CTD PMID:23179753 , PMID:27188386 valsartan multiple interactions ISO RGD:1353912 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of HDAC9 mRNA] CTD PMID:19225232 vincristine decreases expression ISO RGD:1353912 6480464 Vincristine results in decreased expression of HDAC9 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:1353912 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:23891734 , PMID:27188386 vorinostat increases expression ISO RGD:1353912 6480464 vorinostat results in increased expression of HDAC9 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO RGD:1353912 6480464 zoledronic acid results in increased expression of HDAC9 mRNA CTD PMID:24714768